E de Groot
Overview
Explore the profile of E de Groot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hazen A, Sloeserwij V, de Groot E, de Gier J, de Wit N, de Bont A, et al.
BMC Health Serv Res
. 2024 Apr;
24(1):502.
PMID: 38654340
Background: A new interprofessional model incorporating non-dispensing pharmacists in general practice teams can improve the quality of pharmaceutical care. However, results of the model are dependent on the context. Understanding...
2.
Schiffmann L, de Groot E, Albert M, Quaas A, Pinto Dos Santos D, Babic B, et al.
Eur J Surg Oncol
. 2023 Oct;
49(11):107096.
PMID: 37801834
Background: The risk of an anastomotic leakage (AL) following Ivor-Lewis esophagectomy is increased in patients with calcifications of the aorta or a stenosis of the celiac trunc. Ischemic conditioning (ISCON)...
3.
Bremer-Hoeve S, de Groot E, van Wel E, Rutten B, van Bronswijk S
Tijdschr Psychiatr
. 2022 Aug;
64(7):416-4147.
PMID: 36040081
No abstract available.
4.
Roording-Ragetlie S, Spaltman M, de Groot E, Klip H, Buitelaar J, Slaats-Willemse D
J Intellect Disabil Res
. 2021 Nov;
66(1-2):178-194.
PMID: 34755919
Background: Poor working memory, lower IQ and maladaptive behaviour form a triple disability known to have negative effects on the academic and social development of children with borderline intellectual functioning...
5.
Srour S, Singh H, McCarty J, de Groot E, Huls H, Rondon G, et al.
Blood
. 2020 Jan;
135(11):862-865.
PMID: 31961918
No abstract available.
6.
Catalan M, Herreras Z, Pinyol M, Sala-Vila A, Amor A, de Groot E, et al.
Nutr Metab Cardiovasc Dis
. 2015 Jun;
25(8):742-8.
PMID: 26033395
Background And Aims: There is clinical trial evidence that only early, intensive risk factor control can reduce cardiovascular disease (CVD) morbidity and mortality in type 2 diabetes (T2DM). However, there...
7.
Mooij H, Cabrales P, Bernelot Moens S, Xu D, Udayappan S, Tsai A, et al.
J Am Heart Assoc
. 2014 Dec;
3(6):e001274.
PMID: 25468659
Background: Heparanase is the major enzyme involved in degradation of endothelial heparan sulfates, which is associated with impaired endothelial nitric oxide synthesis. However, the effect of heparan sulfate chain length...
8.
Luijendijk P, Bouma B, Vriend J, Groenink M, Vliegen H, de Groot E, et al.
Int J Cardiol
. 2014 Jul;
176(1):40-7.
PMID: 25042661
Background: Carotid intima-media thickness (CIMT) is a marker for atherosclerosis. Adult post-coarctectomy patients (CoA) demonstrate an increased cardiovascular risk and increased CIMT compared to controls. This study evaluates the effect...
9.
Weber G, de Groot E, Schweiger H
Planta
. 2013 Nov;
168(2):273-80.
PMID: 24232032
Cells of Glycine max originating in a suspension culture and cells of Brassica napus prepared from hypocotyls were synchronized. Synchronization was achieved by preparing protoplasts in the usual way and...
10.
Weber G, de Groot E, Schweiger H
J Plant Physiol
. 2012 Dec;
117(4):339-53.
PMID: 23195801
A total of 70 methotrexate-resistant cell lines were isolated from UV-irradiated fast growing suspensions of Glycine max(L.) Merr. The resistant cells grew in 4 X 10(-4) M MTX without significant...